Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568906 · ClinicalTrials.gov registry record
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 129
- Enrollment target
NCT00568906: Clinical Trial study, sponsored by Stanford University.
NCT00568906 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568906 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 129 participants
- Enrollment target
Study Summary
This study will help us understand the gene expression profiles of lung cancer. We will identify genes related to lung cancer development, their growth and metastasis to the lung. In addition, we will examine the role nicotine in the development and progression of lung tumors of smokers, ex-smokers, non-smokers on supplemental nicotine and non smokers with no exposure to nicotine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2002-02 |
| Est. Completion | 2011-10 |
Why NCT00568906 stopped before completion
NCT00568906 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00568906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00568906 about?
NCT00568906 is a clinical study titled "Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma". This study will help us understand the gene expression profiles of lung cancer. We will identify genes related to lung cancer development, their growth and metastasis to the lung. In addition, we will examine the role nicotine in the development and progression of lung tumors of smokers, ex-smokers,...
What is the current status of trial NCT00568906?
This trial is currently terminated. The enrollment target is 129 participants. The study started on 2002-02. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00568906?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia